Development of mRNA–lipid nanoparticle intrabodies against rickettsial infection
Abstract Background Rickettsiosis is among the deadliest vector-borne infectious diseases worldwide, in part because rickettsiae replicate within human cells, where antibodies and most drugs cannot effectively reach this obligatory intracellular pathogen. Ehrlichia chaffeensis, an emerging rickettsi...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-08-01
|
| Seri Bilgileri: | Journal of Biomedical Science |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12929-025-01171-5 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|